vs
AETHLON MEDICAL INC（AEMD）与Anika Therapeutics, Inc.（ANIK）财务数据对比。点击上方公司名可切换其他公司
Anika Therapeutics, Inc.的季度营收约是AETHLON MEDICAL INC的510.6倍（$30.6M vs $60.0K）。Anika Therapeutics, Inc.净利率更高（1.0% vs -2926.4%，领先2927.3%）。Anika Therapeutics, Inc.自由现金流更多（$4.0M vs $-2.0M）
AETHLON MEDICAL INC是一家临床阶段医疗科技企业，专注开发针对性治疗类医疗器械，核心产品血液净化器可从血液中去除有害病毒、肿瘤外泌体及其他病原体，业务聚焦传染病和肿瘤治疗赛道，主要市场覆盖北美地区。
AEMD vs ANIK — 直观对比
营收规模更大
ANIK
是对方的510.6倍
$60.0K
净利率更高
ANIK
高出2927.3%
-2926.4%
自由现金流更多
ANIK
多$6.0M
$-2.0M
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $60.0K | $30.6M |
| 净利润 | $-1.8M | $292.0K |
| 毛利率 | — | 62.6% |
| 营业利润率 | -3026.4% | 2.1% |
| 净利率 | -2926.4% | 1.0% |
| 营收同比 | — | 0.0% |
| 净利润同比 | 49.4% | 101.3% |
| 每股收益（稀释后） | $-10.05 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEMDANIK
| Q4 25 | — | $30.6M | ||
| Q3 25 | — | $27.8M | ||
| Q2 25 | — | $28.2M | ||
| Q1 25 | — | $26.2M | ||
| Q4 24 | $60.0K | $30.6M | ||
| Q3 24 | $95.1K | $29.6M | ||
| Q2 24 | — | $30.7M | ||
| Q1 24 | — | $29.0M |
净利润AEMDANIK
| Q4 25 | — | $292.0K | ||
| Q3 25 | — | $-2.3M | ||
| Q2 25 | — | $-4.0M | ||
| Q1 25 | — | $-4.9M | ||
| Q4 24 | $-1.8M | $-21.9M | ||
| Q3 24 | $-2.8M | $-29.9M | ||
| Q2 24 | — | $-88.0K | ||
| Q1 24 | — | $-4.5M |
毛利率AEMDANIK
| Q4 25 | — | 62.6% | ||
| Q3 25 | — | 56.0% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 56.1% | ||
| Q4 24 | — | 56.0% | ||
| Q3 24 | — | 65.7% | ||
| Q2 24 | — | 66.7% | ||
| Q1 24 | — | 65.4% |
营业利润率AEMDANIK
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | -11.6% | ||
| Q2 25 | — | -14.8% | ||
| Q1 25 | — | -16.4% | ||
| Q4 24 | -3026.4% | -2.3% | ||
| Q3 24 | -3050.2% | -0.3% | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | — | -8.6% |
净利率AEMDANIK
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | -8.4% | ||
| Q2 25 | — | -14.1% | ||
| Q1 25 | — | -18.6% | ||
| Q4 24 | -2926.4% | -71.4% | ||
| Q3 24 | -2950.2% | -101.2% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -15.6% |
每股收益（稀释后）AEMDANIK
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.34 | ||
| Q4 24 | $-10.05 | $-1.49 | ||
| Q3 24 | $-16.11 | $-2.03 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | — | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.8M | $81.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.3M | $143.5M |
| 总资产 | $6.5M | $190.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEMDANIK
| Q4 25 | — | $81.2M | ||
| Q3 25 | — | $80.2M | ||
| Q2 25 | — | $77.1M | ||
| Q1 25 | — | $75.4M | ||
| Q4 24 | $4.8M | $79.2M | ||
| Q3 24 | $6.9M | $90.7M | ||
| Q2 24 | — | $96.6M | ||
| Q1 24 | — | $100.7M |
股东权益AEMDANIK
| Q4 25 | — | $143.5M | ||
| Q3 25 | — | $146.8M | ||
| Q2 25 | — | $147.7M | ||
| Q1 25 | — | $148.4M | ||
| Q4 24 | $4.3M | $154.0M | ||
| Q3 24 | $6.0M | $179.9M | ||
| Q2 24 | — | $210.3M | ||
| Q1 24 | — | $208.5M |
总资产AEMDANIK
| Q4 25 | — | $190.3M | ||
| Q3 25 | — | $189.4M | ||
| Q2 25 | — | $187.7M | ||
| Q1 25 | — | $190.6M | ||
| Q4 24 | $6.5M | $202.7M | ||
| Q3 24 | $8.8M | $231.4M | ||
| Q2 24 | — | $262.7M | ||
| Q1 24 | — | $263.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.0M | $4.6M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | $4.0M |
| 自由现金流率自由现金流/营收 | -3357.0% | 13.0% |
| 资本支出强度资本支出/营收 | 3.7% | 2.1% |
| 现金转化率经营现金流/净利润 | — | 15.88× |
| 过去12个月自由现金流最近4个季度 | — | $4.4M |
8季度趋势，按日历期对齐
经营现金流AEMDANIK
| Q4 25 | — | $4.6M | ||
| Q3 25 | — | $6.9M | ||
| Q2 25 | — | $-189.0K | ||
| Q1 25 | — | $-130.0K | ||
| Q4 24 | $-2.0M | $1.6M | ||
| Q3 24 | $-2.2M | $5.0M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-126.0K |
自由现金流AEMDANIK
| Q4 25 | — | $4.0M | ||
| Q3 25 | — | $5.0M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | $-2.0M | $275.0K | ||
| Q3 24 | — | $3.8M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-1.9M |
自由现金流率AEMDANIK
| Q4 25 | — | 13.0% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | — | -5.9% | ||
| Q1 25 | — | -11.3% | ||
| Q4 24 | -3357.0% | 0.9% | ||
| Q3 24 | — | 12.9% | ||
| Q2 24 | — | -14.6% | ||
| Q1 24 | — | -6.7% |
资本支出强度AEMDANIK
| Q4 25 | — | 2.1% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | — | 5.2% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | 3.7% | 4.3% | ||
| Q3 24 | 0.0% | 4.1% | ||
| Q2 24 | — | 11.1% | ||
| Q1 24 | — | 6.2% |
现金转化率AEMDANIK
| Q4 25 | — | 15.88× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEMD
暂无分部数据
ANIK
| OEM Channel | $17.3M | 57% |
| Commercial Channel | $13.3M | 43% |
